Quantcast

Latest Raja M. Flores Stories

2014-07-11 23:05:26

Scientists say slight inherited differences in the genes may help predict how mesothelioma patients will respond to chemotherapy. Raleigh, NC (PRWEB) July 11, 2014 Cancer researchers in Slovenia say genetic variations called polymorphisms appear to have a significant impact on how patients respond to treatment with pemetrexed (Alimta), the most popular chemotherapy drug for mesothelioma. Surviving Mesothelioma has the full story. Click here to read the new post now. Researchers at the...

2014-07-08 23:09:40

Top mesothelioma researchers say an immunotoxin may have the power to significantly improve the effectiveness of chemotherapy in patients with malignant pleura mesothelioma. Raleigh, NC (PRWEB) July 08, 2014 According to a new NIH research study, more than three quarters of mesothelioma patients responded to chemotherapy when they were also given the anti-mesothelin immunotoxin SS1P. Click here to read Surviving Mesothelioma’s newly-posted article on how this important study may impact...

2014-06-30 23:16:32

There is new evidence that second-line chemotherapy with a drug called gemcitabine can significantly prolong survival in people with malignant pleural mesothelioma. Raleigh, NC (PRWEB) June 30, 2014 A new study out of Turkey finds that mesothelioma patients who have second-line chemotherapy with the antimetabolite, gemcitabine (Gemzar) had a median survival rate 8 months longer than those who had only first-line chemotherapy. Surviving Mesothelioma has just posted a report on the new...

2014-06-25 23:09:30

A nine-year study suggests that mesothelioma patients with excess lung fluid have fewer complications with traditional talc pleurodesis than with video-guided surgery. Raleigh, NC (PRWEB) June 25, 2014 UK researchers studying a procedure called Video-Assisted Thoracoscopic Partial Pleurectomy (VAT-PP) say the traditional, less invasive approach for treating pleural effusions has several advantages for mesothelioma patients. An article on the new findings has just been posted on the...

2014-06-20 23:06:04

Italian researchers say a treatment made from a human protein can help improve the effectiveness of chemotherapy for patients fighting malignant pleural mesothelioma. Raleigh, NC (PRWEB) June 20, 2014 A team of cancer doctors says the combination of a lab-created compound based on a human protein and traditional chemotherapy drugs can help shrink mesothelioma tumors better than either treatment alone. Surviving Mesothelioma has just posted an article on the new research. Click here to...

2014-06-18 23:10:37

A new study of more than 14,000 mesothelioma patients finds that women are much more likely to be alive five years after diagnosis than men are. Raleigh, NC (PRWEB) June 18, 2014 New York researchers say women survive malignant pleural mesothelioma three times as often as do their male counterparts. An article on the new study has just been posted on the Surviving Mesothelioma website. Click here to read it now. Population health experts at North Shore/Long Island Jewish Health System...

2014-06-12 23:08:51

A new study suggests that platinum-based carboplatin reduces hospital stays and produces better outcomes for peritoneal mesothelioma patients than another popular drug. Raleigh, NC (PRWEB) June 12, 2014 Researchers studying the peritoneal mesothelioma treatment approach that combines cytoreductive surgery (CRS) with a wash of heated chemotherapy (HIPEC) have concluded that one drug appears to work better than another for this purpose. Click here to read the details of the article just...

2014-06-11 08:30:14

Immunotherapy treatment, which has potential for long-term improvement with mesothelioma patients, is among the most promising breakthroughs over the last year. LOS ANGELES, June 11, 2014 /PRNewswire/ -- An international roster of malignant pleural mesothelioma (MPM) experts came together on Saturday, May 7, in Santa Monica, Calif., to discuss the latest research findings on this rare asbestos-related cancer. The symposium, which was hosted by UCLA and the Pacific Heart, Lung and...

2014-06-05 23:11:03

The makers of an experimental mesothelioma drug say it may help prevent mesothelioma relapse after chemotherapy. (PRWEB) June 05, 2014 Veratem, Inc., the developers of several experimental drugs that target cancer stem cells, have released an update on their ongoing mesothelioma research. Surviving Mesothelioma has posted an article on the paper. Click here to read it now. Cambridge, Massachusetts-based Verastem researchers say their experiments on mesothelioma cells and in live mice with...

2014-05-29 23:11:56

Wisconsin researchers find many more peritoneal mesothelioma patients could survive if they were treated with surgery. Raleigh, NC (PRWEB) May 29, 2014 A new study of more than 1,500 patients with peritoneal mesothelioma finds that nearly 62 percent of them are not being given the surgical treatment that could dramatically improve their survival. An article on the research has just been posted on the Surviving Mesothelioma website. Click here to read it now. Surgical oncologists at the...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.